149 results on '"Steppe M"'
Search Results
2. Stability-Indication LC Determination of Entacapone in Tablets
3. Photodegradation Kinetics of Fexofenadine Hydrochloride Using a LC Method
4. Determination of dexamethasone acetate in cream by HPLC
5. In-utero carbon monoxide poisoning and multiple fetal abnormalities
6. Abstracts of the Poster Sessions
7. Determination of sitagliptin in the presence of its organic impurities using Box-Behnken experimental design for robustness assessment
8. Stability-Indicating RP-LC Method for the Determination of Vildagliptin and Mass Spectrometry Detection for a Main Degradation Product
9. Stability Indicating LC Method to Determination of Sodium Montelukast in Pharmaceutical Dosage Form and its Photodegradation Kinetics
10. Stability-Indicating LC Assay and Determination of System Suitability Limits with a Robustness Test of Gemifloxacin Mesylate in Tablets
11. LC Determination of Entacapone in Tablets: In Vitro Dissolution Studies
12. LC: Analysis of Photodegradation Kinetics of Nitazoxanide in Pharmaceutical Formulations
13. Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett‐Burman for Robustness Evaluation and Comparison with HPLC
14. Validation of UV Spectrophotometric Method for Fexofenadine Hydrochloride in Pharmaceutical Formulations and Comparison with HPLC
15. Development and Validation of Derivative Spectrophotometric Method for Determination of Rabeprazole Sodium in Pharmaceutical Formulation
16. Microbiological assay for azithromycin in pharmaceutical formulations
17. In-utero carbon monoxide poisoning and multiple fetal abnormalities
18. Les situations d'impuissance face à la maladie: expérience d'une unité de soins intensifs pédiatriques
19. Acute Phosphate Intoxication in seven infants under Parenteral nutrition
20. Accidental ingestion of a sterilising tablet (Dichloroisocyanurate) by a 28 day-old infant
21. Accidental ingestion of a sterilizing tablet (Dichloro-isocyanurate) by a 28 day-old infant
22. Acute Phosphate Intoxication in Seven Infants Under Parenteral Nutrition
23. High frequency jet percussive ventilation in newborns and infants with damaged lungs
24. Blood gases and continuous blood pressure monitoring
25. Medico-surgical emergency transport system in neonates and infants below the age of one year
26. Idiopathic hypereosinophilic syndrome in a neonate.
27. Stability-indicating LC assay and determination of system suitability limits with a robustness test of gemifloxacin mesylate in tablets
28. High Resolution Sensing Techniques for Slope Stability Studies
29. Idiopathic hypereosinophilic syndrome in a neonate
30. Biotransformation of rifampicin by Aspergillus niger and antimicrobial activity of proposed metabolites.
31. A future of AI-driven personalized care for people with multiple sclerosis.
32. Analysis of omarigliptin forced degradation products by ultra-fast liquid chromatography, mass spectrometry, and in vitro toxicity assay.
33. Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation.
34. Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use.
35. Development and validation of capillary zone electrophoresis and high-performance liquid chromatography methods for the determination of oral anticoagulant edoxaban in pharmaceutical tablets.
36. Fast and reliable profiling of cannabinoids in seized samples using the method of HPLC-DAD followed by chemometrics.
37. A set of synthetic data, antibacterial evaluation and bacterial interaction with lipid-core nanocapsules containing fusidic acid.
38. UPLC-ESI/Q-TOF MS/MS Method for Determination of Vildagliptin and its Organic Impurities.
39. Psychosocial needs of patients and spouses justify a position of psychosocial health professionals in the multidisciplinary care for Parkinson's disease.
40. RADPAC-PD: A tool to support healthcare professionals in timely identifying palliative care needs of people with Parkinson's disease.
41. The application of quality by design in the development of the liquid chromatography method to determine empagliflozin in the presence of its organic impurities.
42. "How Long Can I Carry On?" The Need for Palliative Care in Parkinson's Disease: A Qualitative Study from the Perspective of Bereaved Family Caregivers.
43. In vitro toxic evaluation of two gliptins and their main impurities of synthesis.
44. In vitro toxicity assessment of rivaroxaban degradation products and kinetic evaluation to decay process.
45. Palliative care for persons with Parkinson's disease: a qualitative study on the experiences of health care professionals.
46. Microbial transformation of ambrisentan to its glycosides by Cunninghamella elegans.
47. Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA.
48. Quantitative Assessment of Poorly Soluble Anticoagulant Rivaroxaban by Microemulsion Electrokinetic Chromatography.
49. Application of Quality by Design to optimize a stability-indicating LC method for the determination of ticagrelor and its impurities.
50. In vitro dissolution method fitted to in vivo absorption profile of rivaroxaban immediate-release tablets applying in silico data.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.